Semaglutide for Meaningful Weight Loss in Obesity and Diabetes?
A 2.4-mg weekly injection of the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide led to a clinically meaningful 5% loss in weight for roughly two thirds […]
Read more